Table 4.

Interaction analysis between metabolic syndrome and SNAFLD status on mortality

Subgroup		Case	Total number	HR (95% CI)	p value
MetS(−)SNAFLD(−)		62 (12.4)	500	1.000
MetS(+)SNAFLD(−)		49 (31.8)	154	1.845 (1.024–3.323)	0.012*
MetS(−)SNAFLD(+)		21 (30.9)	68	1.910 (1.254–2.908)	0.010*
MetS(+)SNAFLD(+)		23 (54.8)	42	4.958 (2.710–9.071)	0.004*
RERI	2.203 (0.197–4.210)
AP	0.444 (0.222–0.667)
SI	2.256 (1.252–4.065)

SNAFLD, significant non-alcoholic fatty livers disease, MetS metabolic syndrome

*represent the p value < 0.05. MetS metabolic syndrome, SNAFLD significant non-alcoholic fatty liver disease